|
G |
Aco2 |
aconitase 2 |
multiple interactions decreases activity |
ISO |
Aluminum promotes the reaction [Nitroprusside results in decreased activity of ACO2 protein] |
CTD |
PMID:12470706 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Adm |
adrenomedullin |
decreases expression |
EXP |
Nitroprusside results in decreased expression of ADM mRNA |
CTD |
PMID:12899678 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Agt |
angiotensinogen |
decreases response to substance |
ISO |
AGT protein results in decreased susceptibility to Nitroprusside |
CTD |
PMID:18174886 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
AIFM1 protein inhibits the reaction [Nitroprusside results in decreased reduction of Glutathione]; AIFM1 protein promotes the reaction [Nitroprusside results in decreased reduction of Adenine Nucleotides] |
CTD |
PMID:15316071 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
[Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of AKT1 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]; olaparib promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]; PARP1 protein affects the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]; veliparib promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cilomilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]]; Cilomilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]; Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]; Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18276108 PMID:21332719 PMID:30296409 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases activity multiple interactions |
ISO |
Nitroprusside results in decreased activity of ALAD protein Quinolones inhibits the reaction [Nitroprusside results in decreased activity of ALAD protein] |
CTD |
PMID:29317251 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases secretion |
ISO |
APP protein promotes the reaction [Nitroprusside results in decreased activity of CHAT protein] Nitroprusside results in decreased secretion of APP protein alternative form |
CTD |
PMID:10691295 PMID:16724269 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects localization |
EXP ISO |
FGF2 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein]; IGF1 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein] Nitroprusside affects the localization of BAX protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]]; Nitroprusside results in increased expression of and affects the localization of BAX protein; triciribine inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]]; Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased expression of and affects the localization of BAX protein] Nitroprusside results in increased expression of BAX; Nitroprusside results in increased expression of BAX protein [Nitroprusside results in increased abundance of Nitric Oxide] which affects the localization of BAX protein; SB 203580 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which affects the localization of BAX protein] |
CTD |
PMID:10203697 PMID:15961378 PMID:22178905 PMID:22878015 PMID:23665936 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Nitroprusside results in decreased expression of BCL2; Nitroprusside results in decreased expression of BCL2 protein FGF2 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein]; IGF1 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein] [Nitroprusside results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates |
CTD |
PMID:10203697 PMID:15708893 PMID:16980304 PMID:23665936 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
EXP |
MAPK3 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA]; MAPK8 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA] Nitroprusside results in decreased expression of BCL2L1 mRNA; Nitroprusside results in decreased expression of BCL2L1 protein |
CTD |
PMID:20132804 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
affects response to substance |
ISO |
BDKRB2 affects the susceptibility to Nitroprusside |
CTD |
PMID:10614985 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression multiple interactions |
EXP |
Nitroprusside results in decreased expression of BID protein modified form Cilostazol inhibits the reaction [Nitroprusside results in decreased expression of BID protein modified form]; Cilostazol inhibits the reaction [Nitroprusside results in increased cleavage of and results in increased localization of BID protein]; Nitroprusside results in increased cleavage of and results in increased localization of BID protein |
CTD |
PMID:18311796 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Nitroprusside results in decreased expression of BIRC5 protein]; 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA]; NSC 663284 promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA] Nitroprusside results in decreased expression of BIRC5 mRNA; Nitroprusside results in decreased expression of BIRC5 protein |
CTD |
PMID:14988404 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions increases response to substance increases secretion |
EXP |
Flurbiprofen inhibits the reaction [CALCA protein results in increased susceptibility to Nitroprusside]; Indomethacin inhibits the reaction [CALCA protein results in increased susceptibility to Nitroprusside] Nitroprusside results in increased secretion of CALCA protein |
CTD |
PMID:8581270 PMID:18809208 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
EXP |
Nitroprusside affects the cleavage of and affects the expression of CARTPT protein |
CTD |
PMID:12588509 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp12 |
caspase 12 |
multiple interactions increases expression |
EXP |
[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased expression of CASP12 protein Nitroprusside results in increased expression of CASP12 protein |
CTD |
PMID:18675883 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity increases cleavage |
ISO EXP |
Nitroprusside results in increased expression of CASP3 mRNA cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased cleavage of CASP3 protein]; epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP3 protein]; Nitroprusside binds to and results in increased activity of CASP3 protein; Nitroprusside inhibits the reaction [Deferoxamine results in increased activity of CASP3 protein]; Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of CASP3 protein]]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Bortezomib results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased cleavage of CASP3 protein]; [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein; MIR1A-2 mRNA affects the reaction [Nitroprusside results in increased activity of CASP3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Bortezomib results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP3 protein] Nitroprusside results in increased expression of CASP3 protein modified form |
CTD |
PMID:15708893 PMID:16374551 PMID:18311796 PMID:20559625 PMID:22178905 PMID:22878015 PMID:23665936 PMID:25678843 PMID:28484287 PMID:29353218 PMID:30482226 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression increases activity multiple interactions |
ISO EXP |
Nitroprusside results in increased expression of CASP7 mRNA Nitroprusside results in increased activity of CASP7 protein cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein] Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein] |
CTD |
PMID:15708893 PMID:18311796 PMID:22178905 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
EXP ISO |
Nitroprusside results in increased activity of CASP8 protein cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP8 protein] Nitroprusside inhibits the reaction [Deferoxamine results in increased activity of CASP8 protein] [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP8 protein |
CTD |
PMID:16374551 PMID:18311796 PMID:22878015 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
decreases activity increases activity multiple interactions |
ISO |
Nitroprusside results in decreased activity of CASP9 protein Nitroprusside results in increased activity of CASP9 protein epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP9 protein]; Nitroprusside binds to and results in increased activity of CASP9 protein; Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP9 protein] [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein |
CTD |
PMID:22178905 PMID:22543296 PMID:22878015 PMID:23665936 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity decreases activity multiple interactions |
EXP ISO |
Nitroprusside results in increased activity of CAT protein Nitroprusside results in decreased activity of CAT protein Quinolones inhibits the reaction [Nitroprusside results in decreased activity of CAT protein] [Fish Oils co-treated with Nitroprusside] results in increased activity of CAT protein; [Linseed Oil co-treated with Nitroprusside] results in increased activity of CAT protein |
CTD |
PMID:20559625 PMID:25964379 PMID:29317251 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions increases expression |
ISO |
Nitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; Nitroprusside results in increased metabolism of and results in increased stability of CAV1 protein Nitroprusside results in increased expression of CAV1 protein |
CTD |
PMID:19706615 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of CCL2 mRNA |
CTD |
PMID:15153526 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn4 |
cellular communication network factor 4 |
increases expression |
ISO |
Nitroprusside results in increased expression of CCN4 mRNA; Nitroprusside results in increased expression of CCN4 protein |
CTD |
PMID:19238344 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases phosphorylation |
ISO |
Nitroprusside results in decreased phosphorylation of CDK1 protein |
CTD |
PMID:14988404 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
ISO |
Nitroprusside results in increased expression of CEBPB protein alternative form 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of CEBPB protein alternative form] |
CTD |
PMID:30482226 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions decreases activity |
ISO |
APP protein promotes the reaction [Nitroprusside results in decreased activity of CHAT protein] |
CTD |
PMID:16724269 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions increases phosphorylation |
ISO |
[Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of CHUK protein]] which results in decreased localization of NFKB1 protein; Bee Venoms inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]; Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of and results in increased activity of CHUK protein]; Nitroprusside results in increased phosphorylation of and results in increased activity of CHUK protein [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of CHUK protein]] which results in decreased localization of NFKB1 protein; Bee Venoms inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]]; Glutathione inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]]; Hydrogen Peroxide inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]]; Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]; Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of and results in increased activity of CHUK protein]; Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of CHUK protein]; Nitroprusside results in increased phosphorylation of and results in increased activity of CHUK protein |
CTD |
PMID:17067557 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
Nitroprusside results in decreased expression of COL1A2 mRNA |
CTD |
PMID:22543296 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
affects response to substance |
ISO |
CPS1 gene SNP affects the susceptibility to Nitroprusside |
CTD |
PMID:14718356 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cilomilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]]; Cilomilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]]; Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]; Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:18276108 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions increases secretion |
EXP |
beta-Endorphin inhibits the reaction [Nitroprusside results in increased secretion of CRH protein]; Corticosterone affects the reaction [Nitroprusside results in increased secretion of CRH protein]; Dynorphins inhibits the reaction [Nitroprusside results in increased secretion of CRH protein]; Nitroprusside results in increased expression of and results in increased secretion of CRH protein; Yohimbine inhibits the reaction [Nitroprusside results in increased expression of and results in increased secretion of CRH protein] |
CTD |
PMID:3015567 PMID:3031743 PMID:3497798 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Nitroprusside results in increased expression of DDIT3 protein 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of DDIT3 protein]; Nitroprusside inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Nitroprusside inhibits the reaction [Bortezomib results in increased expression of DDIT3 protein]; Nitroprusside inhibits the reaction [Chloroquine results in increased expression of DDIT3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of DDIT3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Nitroprusside promotes the reaction [Bortezomib results in increased expression of DDIT3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased expression of DDIT3 protein] |
CTD |
PMID:30482226 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Nitroprusside inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein]; Nitroprusside inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Nitroprusside inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16023617 PMID:16389725 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn3 |
endothelin 3 |
multiple interactions decreases expression |
EXP |
Nitroprusside inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein] Nitroprusside results in decreased expression of EDN3 protein |
CTD |
PMID:7982458 PMID:16023617 |
|
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
Nitroprusside inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein]; Nitroprusside inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein] |
CTD |
PMID:16023617 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
multiple interactions decreases expression |
EXP |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroprusside results in decreased expression of ENPP1 protein]; 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine promotes the reaction [Nitroprusside results in decreased expression of ENPP1 protein] |
CTD |
PMID:21414308 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Epo |
erythropoietin |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] |
CTD |
PMID:11286986 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Nitroprusside]; ESR1 protein affects the susceptibility to [Lipopolysaccharides co-treated with Phenylephrine co-treated with Nitroprusside] |
CTD |
PMID:17158209 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions decreases response to substance |
EXP ISO |
FGF2 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein]; FGF2 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein] FGF2 protein results in decreased susceptibility to Nitroprusside |
CTD |
PMID:10203697 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions affects expression |
ISO EXP |
Nitroprusside results in increased expression of FOS protein [Nitroprusside co-treated with Urethane co-treated with Chloralose] results in increased expression of FOS protein; [Nitroprusside co-treated with Urethane] affects the expression of FOS protein Nitroprusside results in increased expression of FOS mRNA; Nitroprusside results in increased expression of FOS protein Nitroprusside affects the expression of FOS protein |
CTD |
PMID:7844257 PMID:8294911 PMID:8698450 PMID:8750937 PMID:11588591 PMID:12088752 PMID:15059776 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases activity |
EXP |
Nitroprusside results in decreased activity of FBP protein |
CTD |
PMID:25964379 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
ISO EXP |
Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of G6PD mRNA] Nitroprusside results in decreased activity of G6PD protein Linseed Oil inhibits the reaction [Nitroprusside results in decreased activity of G6PD protein] |
CTD |
PMID:17018880 PMID:25964379 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of GNAI2 protein |
CTD |
PMID:16962941 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of GNAI3 protein |
CTD |
PMID:16962941 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
multiple interactions |
ISO |
GOSR1 protein affects the reaction [Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK1 protein]]; GOSR1 protein affects the reaction [Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK3 protein]]; GOSR1 protein affects the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]; MAPK3 protein affects the reaction [GOSR1 protein affects the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:31066958 |
|
NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
EXP |
Fish Oils inhibits the reaction [Nitroprusside results in increased activity of GPT protein]; Linseed Oil inhibits the reaction [Nitroprusside results in increased activity of GPT protein] |
CTD |
PMID:25964379 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
affects response to substance |
ISO |
GRK3 mutant form affects the susceptibility to Nitroprusside |
CTD |
PMID:10198406 |
|
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP ISO |
Nitroprusside results in decreased phosphorylation of and results in increased activity of GSK3B protein |
CTD |
PMID:29353218 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
multiple interactions |
EXP |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(2-(4-chlorophenylsulfanyl)phenyl)-N-(4-dimethylaminobutyl)acrylamide promotes the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Nitroprusside promotes the reaction [3-(2-(2,2-dimethylpropylsulfanyl)pyridin-3-yl)-N-(3-hydroxycyclohexyl)acrylamide results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:12495780 PMID:17050951 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions |
EXP |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(2-(4-chlorophenylsulfanyl)phenyl)-N-(4-dimethylaminobutyl)acrylamide promotes the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Nitroprusside promotes the reaction [3-(2-(2,2-dimethylpropylsulfanyl)pyridin-3-yl)-N-(3-hydroxycyclohexyl)acrylamide results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Nitroprusside results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:12495780 PMID:17050951 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases activity decreases expression multiple interactions |
ISO |
Nitroprusside results in decreased activity of HIF1A protein Nitroprusside results in decreased expression of HIF1A mRNA; Nitroprusside results in decreased expression of HIF1A protein Nitroprusside inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:11286986 PMID:15465035 PMID:28624453 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
[linsidomine co-treated with Nitroprusside] results in increased expression of HMOX1 mRNA; [Nitroprusside results in increased abundance of nitrosonium ion] which results in increased expression of HMOX1 mRNA; Dactinomycin inhibits the reaction [Nitroprusside results in increased expression of HMOX1 mRNA]; IFNG protein inhibits the reaction [Nitroprusside results in increased expression of HMOX1 mRNA]; Nitroprusside promotes the reaction [S-Nitrosoglutathione results in increased expression of HMOX1 mRNA]; S-Nitrosoglutathione promotes the reaction [Nitroprusside results in increased expression of HMOX1 mRNA] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein]; Cilostazol inhibits the reaction [Nitroprusside results in decreased expression of HMOX1 protein]; Deferoxamine inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein]; KT 5720 inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein] Nitroprusside results in increased expression of HMOX1 mRNA; Nitroprusside results in increased expression of HMOX1 protein |
CTD |
PMID:8764571 PMID:10349844 PMID:10423162 PMID:12393473 PMID:16439612 PMID:18311796 PMID:29353218 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
multiple interactions |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in decreased expression of HNRNPDL mRNA |
CTD |
PMID:12393473 |
|
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
multiple interactions |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in decreased expression of HSPA1L mRNA |
CTD |
PMID:12393473 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
EXP |
Nitroprusside results in increased expression of HSPA5 protein [Nitroprusside results in increased abundance of Nitric Oxide] which results in decreased expression of HSPA5 protein |
CTD |
PMID:18675883 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of HSPD1 protein] |
CTD |
PMID:17855661 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Ibsp |
integrin-binding sialoprotein |
multiple interactions increases expression |
ISO |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroprusside results in increased expression of IBSP mRNA] |
CTD |
PMID:22543296 |
|
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
|
|
G |
Ifng |
interferon gamma |
decreases expression multiple interactions |
ISO EXP |
Nitroprusside results in decreased expression of IFNG mRNA [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of CCL2 mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of NFKBIA mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of TLR2 mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of TNF mRNA IFNG protein inhibits the reaction [Nitroprusside results in increased expression of HMOX1 mRNA]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:9201699 PMID:10349844 PMID:11076874 PMID:15153526 PMID:15580020 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases response to substance multiple interactions |
ISO EXP |
IGF1 protein results in decreased susceptibility to Nitroprusside IGF1 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein]; IGF1 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein] |
CTD |
PMID:10203697 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions increases activity |
ISO |
Bee Venoms inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]; Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein] Bee Venoms inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]]; Glutathione inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]]; Hydrogen Peroxide inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]]; Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein] |
CTD |
PMID:17067557 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL10 mRNA |
CTD |
PMID:15580020 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL1A mRNA |
CTD |
PMID:15580020 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO EXP |
Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of IL1B protein]] Nitroprusside results in decreased expression of IL1B mRNA |
CTD |
PMID:11076874 PMID:15580020 PMID:28484287 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL2 mRNA |
CTD |
PMID:15580020 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL3 mRNA |
CTD |
PMID:15580020 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions increases expression |
ISO EXP |
Nitroprusside results in decreased expression of IL4 mRNA Cyclosporine inhibits the reaction [Nitroprusside results in increased expression of IL4 mRNA] |
CTD |
PMID:9201699 PMID:15580020 PMID:16533816 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL5 mRNA |
CTD |
PMID:15580020 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of IL6 mRNA |
CTD |
PMID:15580020 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgb3 |
integrin subunit beta 3 |
multiple interactions |
ISO |
[Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of AKT1 protein; [Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; [Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:21332719 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects localization |
EXP |
Nitroprusside affects the localization of JUN protein |
CTD |
PMID:20132804 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Nitroprusside results in increased expression of JUNB mRNA |
CTD |
PMID:8294911 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
affects activity |
EXP |
Nitroprusside affects the activity of KCNJ2 protein |
CTD |
PMID:14993195 |
|
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kng1 |
kininogen 1 |
decreases activity |
EXP |
Nitroprusside results in decreased activity of KNG1 |
CTD |
PMID:1334751 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lta |
lymphotoxin alpha |
decreases expression |
EXP |
Nitroprusside results in decreased expression of LTA mRNA |
CTD |
PMID:15580020 |
|
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases expression |
EXP |
Nitroprusside results in decreased expression of LTC4S mRNA |
CTD |
PMID:17496435 |
|
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
ISO |
[MAOB protein co-treated with MAOA protein] affects the susceptibility to Nitroprusside |
CTD |
PMID:11834493 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
[MAOB protein co-treated with MAOA protein] affects the susceptibility to Nitroprusside |
CTD |
PMID:11834493 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions increases phosphorylation decreases expression |
ISO EXP |
Nitroprusside results in decreased phosphorylation of MAPK1 protein [Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK1 protein]; GOSR1 protein affects the reaction [Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK1 protein]] N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Nitroprusside results in increased phosphorylation of MAPK1 protein]; Nitroprusside inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] Nitroprusside results in decreased expression of MAPK1 protein modified form |
CTD |
PMID:15486966 PMID:16389725 PMID:16439612 PMID:20132804 PMID:21332719 PMID:31066958 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions increases phosphorylation affects response to substance decreases expression |
ISO EXP |
Nitroprusside results in decreased phosphorylation of MAPK3 protein MAPK3 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Nitroprusside results in increased phosphorylation of MAPK3 protein]; Nitroprusside inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein] [Nitroprusside results in increased expression of ITGB3 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK3 protein]; GOSR1 protein affects the reaction [Deferoxamine inhibits the reaction [Nitroprusside results in decreased phosphorylation of MAPK3 protein]]; MAPK3 protein affects the reaction [GOSR1 protein affects the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]] MAPK3 protein affects the susceptibility to Nitroprusside Nitroprusside results in decreased expression of MAPK3 protein modified form |
CTD |
PMID:15486966 PMID:16389725 PMID:16439612 PMID:20132804 PMID:21332719 PMID:31066958 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression multiple interactions affects response to substance |
EXP |
Nitroprusside results in decreased expression of MAPK8 protein modified form MAPK8 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA] MAPK8 protein affects the susceptibility to Nitroprusside |
CTD |
PMID:20132804 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
EXP |
Nitroprusside results in decreased expression of MAPK9 protein modified form |
CTD |
PMID:20132804 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Deferoxamine results in increased cleavage of MCL1 protein] |
CTD |
PMID:16374551 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
affects expression |
EXP |
Nitroprusside affects the expression of MGST2 mRNA |
CTD |
PMID:17496435 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
affects expression |
EXP |
Nitroprusside affects the expression of MGST3 mRNA |
CTD |
PMID:17496435 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Mir1 |
microRNA 1 |
multiple interactions increases expression |
ISO |
MIR1A-2 mRNA affects the reaction [Nitroprusside results in increased activity of CASP3 protein] Nitroprusside results in increased expression of MIR1A-2 mRNA |
CTD |
PMID:25678843 |
|
NCBI chr18:1,887,537...1,887,623
|
|
G |
Mir135b |
microRNA 135b |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of CASP3 protein]]; Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of IL1B protein]]; Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of TNF protein]] |
CTD |
PMID:28484287 |
|
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
|
|
G |
Mt1 |
metallothionein 1 |
increases expression multiple interactions |
ISO |
Nitroprusside results in increased expression of MT1A mRNA N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of MT1A mRNA]; Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of MT1A mRNA] |
CTD |
PMID:17018880 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression multiple interactions |
ISO |
Nitroprusside results in increased expression of MT1E mRNA N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of MT1E mRNA]; Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of MT1E mRNA] |
CTD |
PMID:17018880 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in increased expression of MT2A mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of MT2A mRNA]; Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of MT2A mRNA] |
CTD |
PMID:12393473 PMID:17018880 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
multiple interactions increases expression |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of MTF1 mRNA]; Nitroprusside promotes the reaction [Zinc Sulfate results in increased expression of MTF1 mRNA] |
CTD |
PMID:17018880 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
decreases activity |
EXP |
Nitroprusside results in decreased activity of MTR protein |
CTD |
PMID:9108260 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Nitroprusside results in decreased expression of MYC mRNA |
CTD |
PMID:7798212 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
ISO EXP |
Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] Nitroprusside results in decreased expression of NFE2L2 protein Deferoxamine inhibits the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]; GOSR1 protein affects the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]; MAPK3 protein affects the reaction [GOSR1 protein affects the reaction [Nitroprusside results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:29353218 PMID:31066958 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases activity increases localization affects localization |
ISO EXP |
[Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of CHUK protein]] which results in decreased localization of NFKB1 protein; [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]] which results in decreased localization of NFKB1 protein; Bee Venoms inhibits the reaction [Nitroprusside results in increased localization of NFKB1 protein]; Melitten inhibits the reaction [Nitroprusside results in increased localization of NFKB1 protein]; pyrazolanthrone inhibits the reaction [Bee Venoms inhibits the reaction [Nitroprusside results in increased localization of NFKB1 protein]]; pyrazolanthrone inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased localization of NFKB1 protein]] Nitroprusside results in increased activity of NFKB1 protein Nitroprusside affects the localization of NFKB1 protein |
CTD |
PMID:17067557 PMID:17496435 PMID:18507870 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases phosphorylation |
ISO |
[Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]] which results in decreased localization of NFKB1 protein; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of NFKBIA mRNA; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]]; Glutathione inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]]; Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein] [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]] which results in decreased localization of NFKB1 protein; Bee Venoms inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]; Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]; pyrazolanthrone inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]] |
CTD |
PMID:15153526 PMID:17067557 PMID:18507870 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS1 protein] |
CTD |
PMID:17855661 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases activity increases expression decreases expression |
ISO EXP |
[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] Nitroprusside results in decreased activity of NOS2 protein Nitroprusside results in increased expression of NOS2 mRNA; Nitroprusside results in increased expression of NOS2 protein [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Nitroprusside inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Nitroprusside]; Plant Extracts inhibits the reaction [Nitroprusside results in increased expression of NOS2 mRNA]; Plant Extracts inhibits the reaction [Nitroprusside results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] Nitroprusside results in decreased expression of NOS2 mRNA |
CTD |
PMID:11076874 PMID:11498454 PMID:17067557 PMID:17496435 PMID:18507870 PMID:25829766 PMID:30524225 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases expression |
ISO EXP |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein] Nitroprusside results in increased expression of NOS3 mRNA |
CTD |
PMID:17496435 PMID:17855661 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
Nitroprusside results in decreased expression of NPPB protein |
CTD |
PMID:20339970 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions decreases expression |
EXP ISO |
Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NQO1 protein] Nitroprusside results in decreased expression of NQO1 protein |
CTD |
PMID:29353218 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
PARP1 protein affects the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:30296409 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plg |
plasminogen |
decreases response to substance |
EXP |
PLG protein results in decreased susceptibility to Nitroprusside |
CTD |
PMID:9710261 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions increases secretion |
EXP |
Corticosterone inhibits the reaction [Nitroprusside results in increased secretion of POMC protein]; Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; nonylphenol inhibits the reaction [Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]] |
CTD |
PMID:3015567 PMID:20837582 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] |
CTD |
PMID:17855661 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prnp |
prion protein |
multiple interactions |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in increased expression of PRNP mRNA |
CTD |
PMID:12393473 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Nitroprusside inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] [Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Melitten inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Nitroprusside inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 mRNA]; Nitroprusside inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]; pyrazolanthrone inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] |
CTD |
PMID:16874658 PMID:17067557 PMID:18507870 PMID:28624453 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
increases expression |
EXP |
Nitroprusside results in increased expression of RAMP2 mRNA |
CTD |
PMID:12899678 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
multiple interactions |
EXP |
Nitroprusside results in increased nitrosation of and results in increased activity of RASD1 protein |
CTD |
PMID:16908409 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases activity increases localization affects localization |
ISO EXP |
Bee Venoms inhibits the reaction [Nitroprusside results in increased localization of RELA protein]; Melitten inhibits the reaction [Nitroprusside results in increased localization of RELA protein]; pyrazolanthrone inhibits the reaction [Bee Venoms inhibits the reaction [Nitroprusside results in increased localization of RELA protein]]; pyrazolanthrone inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased localization of RELA protein]] Nitroprusside results in increased activity of RELA protein Nitroprusside affects the localization of RELA protein |
CTD |
PMID:17067557 PMID:17496435 PMID:18507870 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
multiple interactions increases activity |
ISO EXP |
[Halothane co-treated with Nitroprusside] results in increased activity of REN protein; bunitrolol inhibits the reaction [Nitroprusside results in increased activity of REN protein]; esmolol inhibits the reaction [Nitroprusside results in increased activity of REN protein]; Nitroprusside promotes the reaction [Anesthetics, Combined results in increased activity of REN protein]; Propranolol affects the reaction [Nitroprusside promotes the reaction [Anesthetics, Combined results in increased activity of REN protein]]; Propranolol inhibits the reaction [Nitroprusside results in increased activity of REN protein] Nitroprusside affects the reaction [Sodium affects the activity of REN protein] |
CTD |
PMID:453612 PMID:1867428 PMID:2413294 PMID:2569849 PMID:3152422 PMID:3281763 PMID:6113146 PMID:6434220 PMID:7009830 PMID:7020487 PMID:7351115 More...
|
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retn |
resistin |
decreases expression |
ISO |
Nitroprusside results in decreased expression of RETN mRNA |
CTD |
PMID:18369347 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
S100b |
S100 calcium binding protein B |
increases secretion multiple interactions |
EXP |
Nitroprusside results in increased secretion of S100B protein resveratrol inhibits the reaction [Nitroprusside results in increased secretion of S100B protein] |
CTD |
PMID:23284918 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
Nitroprusside results in increased expression of and results in increased activity of SIRT1 protein |
CTD |
PMID:18204789 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:12393473 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions increases expression |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of SLC30A1 mRNA]; Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of SLC30A1 mRNA] |
CTD |
PMID:17018880 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein]; [Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein] |
CTD |
PMID:20674559 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases response to substance |
ISO |
1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein]; [Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein] SOD2 protein results in increased susceptibility to Nitroprusside |
CTD |
PMID:10511315 PMID:20674559 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions increases expression |
ISO |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroprusside results in increased expression of SPP1 mRNA] |
CTD |
PMID:22543296 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases cleavage multiple interactions |
ISO |
Nitroprusside results in increased cleavage of SPTAN1 protein rosiglitazone inhibits the reaction [Nitroprusside results in increased cleavage of SPTAN1 protein] |
CTD |
PMID:19226370 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G |
Tacr1 |
tachykinin receptor 1 |
increases response to substance |
EXP |
TACR1 protein results in increased susceptibility to Nitroprusside |
CTD |
PMID:16982039 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
[Nitroprusside results in increased abundance of nitrosonium ion] which results in decreased expression of TFRC mRNA |
CTD |
PMID:12393473 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions increases expression |
EXP |
[Nitroprusside co-treated with Urethane co-treated with Chloralose] results in increased expression of TH protein; Nitroprusside inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein]; Nitroprusside inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein] Nitroprusside results in increased expression of TH protein |
CTD |
PMID:12088752 PMID:16023617 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tlr2 |
toll-like receptor 2 |
multiple interactions |
ISO |
[Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of TLR2 mRNA |
CTD |
PMID:15153526 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnf |
tumor necrosis factor |
decreases response to substance multiple interactions decreases expression |
EXP ISO |
TNF protein results in decreased susceptibility to Nitroprusside Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Nitroprusside inhibits the reaction [MIR135B mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of TNF protein]] [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of CCL2 mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of NFKBIA mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of TLR2 mRNA; [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of TNF mRNA Nitroprusside results in decreased expression of TNF mRNA |
CTD |
PMID:9710261 PMID:11076874 PMID:15153526 PMID:15580020 PMID:28484287 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression increases phosphorylation |
EXP ISO |
cilostazol inhibits the reaction [Nitroprusside results in increased phosphorylation of TP53 protein] Nitroprusside results in increased expression of TP53 protein |
CTD |
PMID:15979383 PMID:18311796 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions increases expression |
ISO |
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [Bortezomib results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased expression of TRIB3 protein] |
CTD |
PMID:30482226 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
ISO |
Nitroprusside promotes the reaction [anandamide binds to and results in increased activity of TRPV1 protein] |
CTD |
PMID:11278420 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA] |
CTD |
PMID:11286986 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Xanthine co-treated with XDH protein] inhibits the reaction [Nitroprusside results in increased abundance of Cyclic GMP] |
CTD |
PMID:17339839 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|